About Binax
Binax is a company based in Portland (United States) founded in 1986 was acquired by Abbott in February 2005. Binax offers products and services including BinaxNOW COVID-19 Antigen Self Test and BinaxNOW COVID-19/Flu A&B Combo Self Test. Binax operates in a competitive market with competitors including Inflammatix, Karius, MeMed, Visby Medical and GenMark Diagnostics, among others.
- Headquarter Portland, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Abbott
(Feb 07, 2005)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Binax
Binax offers a comprehensive portfolio of products and services, including BinaxNOW COVID-19 Antigen Self Test and BinaxNOW COVID-19/Flu A&B Combo Self Test.
Rapid at-home test for detecting COVID-19 proteins.
Combined test for COVID-19 and influenza A and B detection.
Funding Insights of Binax
Detailed funding history for Binax
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Binax
Binax has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Abbott Global Point of Care.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Rapid diagnostics products and solutions for point-of-care testing are provided.
|
Locked | Locked | Locked |
Investor details for Binax
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Binax
Investment portfolio details for Binax
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Binax
Detailed financials for Binax
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Binax Comparisons
Peer comparison for Binax
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Binax
Binax operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inflammatix, Karius, MeMed, Visby Medical and GenMark Diagnostics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of diagnostic solutions for systemic infections
|
|
| Locked | Locked | Locked |
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
|
|
| Locked | Locked | Locked |
Provider of machine learning based diagnostic solutions for infectious diseases
|
|
| Locked | Locked | Locked |
Portable PCR diagnostics for infectious diseases are developed.
|
|
| Locked | Locked | Locked |
Instruments and test panels for multiplexed molecular diagnostics are provided.
|
|
| Locked | Locked | Locked |
Diagnostic technologies for infectious, cancer, and neurological diseases are developed.
|
Detailed competitors of Binax
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Binax
Complete news archive for Binax
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Binax
Binax was founded in 1986.
Binax is headquartered in Portland, United States. It is registered at Portland, Oregon, United States.
Binax is focused in the development, manufacture, and marketing of a wide range of diagnostic tests for infectious diseases. The company sells a range of lateral flow immunochromatographic assay based tests for Legionella pneumophila, Streptococcus pneumoniae, Strep A, Flu A, Flu B, Ragged stunt virus, NOW Malaria, Hepatitis B, and Filariasis tests. The company was acquired by Inverness Medical Innovations, Inc in Feb, 2005.
Binax's top competitors include Visby Medical, Inflammatix and MeMed.
Binax offers BinaxNOW COVID-19 Antigen Self Test and BinaxNOW COVID-19/Flu A&B Combo Self Test.
Binax has 1 investor. Key investors include Abbott Global Point of Care.